Comparison of carbohydrate metabolism during the night and at hypoglycemia in type-2 diabetic patients either on glargine [insulin glargine] or NPH insulin [insulin suspension isophane]

Trial Profile

Comparison of carbohydrate metabolism during the night and at hypoglycemia in type-2 diabetic patients either on glargine [insulin glargine] or NPH insulin [insulin suspension isophane]

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2008

At a glance

  • Drugs Insulin glargine; Insulin suspension isophane
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top